Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02199795 · ClinicalTrials.gov registry record · NA

Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in Stroke

A NA study, sponsored by MetroHealth Medical Center.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT02199795 is a NA study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02199795, a NA study, has completed, sponsored by MetroHealth Medical Center.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

This is a small pilot randomized controlled trial which will enroll both subacute (\<6 mos) and chronic (\>6 mos) stroke survivors with ankle dorsiflexion weakness. The subjects will be randomized to Contralaterally Controlled Neuromuscular Electrical Stimulation (CCNMES) versus control. The primary objective of this study is to compare the effect of 6-weeks of lower extremity CCNMES, applied in an anti-phase application, on motor impairment and functional mobility to a control group.

Interventions

  • DEVICE Contralaterally Controlled Neuromuscular Electrical Stimulation
  • DEVICE Cyclic Neuromuscular Electrical Stimulation

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2014-05
Est. Completion 2015-02
Phase NA

Sponsor

MetroHealth Medical Center

76 total trials

What the Registry Record Tells You About NCT02199795

The ClinicalTrials.gov registry entry for NCT02199795 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Contralaterally Controlled Neuromuscular Electrical Stimulation is the first listed.

NCT02199795 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02199795 about?

NCT02199795 is a clinical study titled "Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in Stroke". This is a small pilot randomized controlled trial which will enroll both subacute (\<6 mos) and chronic (\>6 mos) stroke survivors with ankle dorsiflexion weakness. The subjects will be randomized to Contralaterally Controlled Neuromuscular Electrical Stimulation (CCNMES) versus control. The primary...

What is the current status of trial NCT02199795?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-05. Estimated completion is 2015-02.

What interventions are being tested in trial NCT02199795?

The interventions under investigation include: Contralaterally Controlled Neuromuscular Electrical Stimulation (DEVICE), Cyclic Neuromuscular Electrical Stimulation (DEVICE).

Who is sponsoring clinical trial NCT02199795?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.